Literature DB >> 16329625

Soluble ST2 protein in cardiac surgery: a possible negative feedback loop to prevent uncontrolled inflammatory reactions.

Tamás Szerafin1, Markus Brunner, Ambrus Horváth, Lajos Szentgyörgyi, Bernhard Moser, George Boltz-Nitulescu, Arpád Péterffy, Konrad Hoetzenecker, Barbara Steinlechner, Ernst Wolner, Hendrik Jan Ankersmit.   

Abstract

BACKGROUND: Recent reports have demonstrated that cardiopulmonary bypass (CBP) utilization leads to a TH2 cytokine bias in patients undergoing coronary artery bypass grafting (CABG) operation. The relation of soluble ST2 and secretion of IL-10, markers of TH2 T-cell activation, and IL-13 in relation to immunoglobulin isotope production is not known in patients undergoing On- versus Off-pump (CABG) procedure.
METHODS: 30 patients were prospectively included in the study (On- vs Off-pump CABG, each n = 15). Serum samples were obtained prior to, and 30 min, 60 min and 24hrs after operation. ELISA was utilized to detect sST2 and IL-10, IL-13 and immunoglobulin isotype production.
RESULTS: In both cohorts we could demonstrate a significant rise of ST2 24 hours after the CABG procedure. In the On-pump group ST2 levels (pg/ml) before the operation, at 30 and 60 minutes and after 24 hours were 115.3 +/- 25, 71.2 +/- 15, 114.1 +/- 26 and 4231.9 +/- 520, respectively. In the Off-pump group they were 200.3 +/- 109, 91.2 +/- 20, 137 +/- 29 and 4144.9 +/- 488 (both, p < 0.0001, p < 0.0001, respectively). IL-10 (pg/ml) levels rose from preoperative values of 6.2 +/- 1.6 in the On-pump group and 7.91 +/- 1.8 in the Off-pump group to 33.14 +/- 8.7 and 13.72 +/- 3 after 60 minutes (p 0.0189, p 0.0397, respectively). IL-13 levels and immunoglobulin production did not change significantly within the study period irrespective of the operation procedure used.
CONCLUSION: In conclusion, our results demonstrate that sST2 and IL-10, markers of TH2 cytokine producing cells, are increased in CABG operation, irrespective of the procedure selected, and settles a longstanding controversy concerning the shift from Th1 to Th2 cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16329625

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  5 in total

Review 1.  Meta-analysis of interleukin 6, 8, and 10 between off-pump and on-pump coronary artery bypass groups.

Authors:  Fanbo Meng; Jianghong Ma; Wei Wang; Baisong Lin
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

2.  Increased soluble serum markers caspase-cleaved cytokeratin-18, histones, and ST2 indicate apoptotic turnover and chronic immune response in COPD.

Authors:  Stefan Hacker; Christopher Lambers; Andreas Pollreisz; Konrad Hoetzenecker; Michael Lichtenauer; Andreas Mangold; Tina Niederpold; Andreas Hacker; György Lang; Martin Dworschak; Thomas Vukovich; Christopher Gerner; Walter Klepetko; Hendrik Jan Ankersmit
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

3.  Role of IL-33 in inflammation and disease.

Authors:  Ashley M Miller
Journal:  J Inflamm (Lond)       Date:  2011-08-26       Impact factor: 4.981

4.  Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery.

Authors:  Sai Polineni; Devin M Parker; Shama S Alam; Heather Thiessen-Philbrook; Eric McArthur; Anthony W DiScipio; David J Malenka; Chirag R Parikh; Amit X Garg; Jeremiah R Brown
Journal:  J Am Heart Assoc       Date:  2018-07-07       Impact factor: 5.501

5.  Transient perioperative inflammation following lung transplantation and major thoracic surgery with elective extracorporeal support: a prospective observational study.

Authors:  Cecilia Veraar; Stefan Schwarz; Jürgen Thanner; Martin Direder; Panja M Boehm; Leopold Harnoncourt; Joachim Ortmayr; Clarence Veraar; Julia Mascherbauer; Walter Klepetko; Martin Dworschak; Hendrik J Ankersmit; Bernhard Moser
Journal:  Ann Transl Med       Date:  2021-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.